Makardhwaj Shrivastava
Hematology & Oncology · Phoenix, AZNPI 1871844258
Payments from drug & device makers
What this record shows
That places this record below the midpoint for hematology & oncology clinicians in AZ, where the typical reported total is $6,870.
Across 2 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Karyopharm Therapeutics Inc.$24
- Bristol Myers Squibb$17
Across 3 payments — averaging $99,142 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$297K
What the payments were for
- Food & beverage$1741%
- Education$2459%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $17 |
How this compares
$41 in reported general payments places this provider in the 0th percentile of 261 hematology & oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 32 | $523,931 |
| JakafiRuxolitinib Phosphate | 16 | $266,868 |
| EliquisApixaban | 17 | $10,818 |
| Exemestane | 21 | $2,628 |
| Letrozole | 59 | $1,277 |
| Ondansetron OdtOndansetron | 34 | $611 |
| Prochlorperazine Maleate | 30 | $386 |
| Dexamethasone | 11 | $178 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $178 |
| Acyclovir | 29 | $175 |
| Hydroxyurea | 12 | $136 |
| Anastrozole | 13 | $134 |
| LoperamideLoperamide Hcl | 12 | $91 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Phoenix
- Javier MunozPhoenix$638K
- Mazen KhattabPhoenix$186K
- Robert GalamagaPhoenix$168K
- Panayiotis SavvidesPhoenix$153K
- Robert YooPhoenix$44K
- Sunil TulpulePhoenix$36K
- Tania CortasPhoenix$33K
- Mahesh SeetharamPhoenix$30K
- Boo Ghee LowPhoenix$25K
- Sujith KalmadiChandler$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.